Search

By Industry Solutions (2)
By Phase (1)
By Molecule Type (1)
By Therapeutic Area (3)
Covance Events (9)
Geography (3)
Keywords (10)

Filters

Showing results 785 - 800 of 91813 for .

Showing results 785 - 800 of 91813 for .

High-Quality Resourcing Delivers Solutions Made Real: Flexible Solutions Case Study
High-Quality Resourcing Delivers Solutions Made Real: Flexible Solutions Case Study
Inflammation Clinical Trial Services COPD Case Study
Inflammation Clinical Trial Services COPD Case Study
Inflammation Clinical Trial Services: Psoriasis Program Case Study
Inflammation Clinical Trial Services: Psoriasis Program Case Study
Informed Pricing Strategy: A Case Study on Value-Based Pricing Research
Learn how research helped to unify the client's understanding of the product's value internally and provided strong evidence to justify the launch strategy and price point.
Creative Recruitment Solutions Expedites Phase I Study: Japanese Bridging Case Study
Creative Recruitment Solutions Expedites Phase I Study: Japanese Bridging Case Study
Hybrid Protocol. Accelerated Success.
A case study for the Covance Clinical Research Unit in Leeds, England
Helping a Small Biotech Find the Most Cost-Effective Solution to Logistical Challenges
A small European biotech company had a drug candidate targeting dementia and needed a partner who could run a unique biomarker assay in clinical trial testing. The client originally assumed that Covance was too large and focused solely on large pharmaceutical manufacturers. However, after spending time discussing the challenges and potential solutions with the Covance client lead, the client ultimately selected Covance as their partner.
Real-time Data. Expert Analysis. High Recovery: A Radioanalysis Case Study.
A case study for the Covance Clinical Research Unit in Madison, WI
Manage Complexity. Exceed Expectations. Clinical Oncology Success Case Study
Learn how in-depth collaboration during a complex program help sped the development process, saving time and money.
Meeting Aggressive Enrollment Schedules With The Xcellerate® Informatics Suite
A large pharmaceutical company selected Covance to conduct a 3-year global study of a novel treatment targeting a rare pediatric metabolic disease. Understanding the Challenge: • Very limited, highly-targeted patient population • Coordination required with consortiums across the US and EU • Tight enrollment timelines to recruit in a sparse patient population
Cohesive Services to Support a Rare Disease Clinical Program
A Case Study in Mining LabCorp Data to Assess Study Feasibility.
Standing Our Ground for Your Data Quality - Nasal Secretion ECP Assay Validation with Expanded Laboratory Management Solutions (ELMS)
Eosinophil cationic protein (ECP) is a biomarker sometimes used to assess levels of inflammation or allergic response in various body tissues. It may be used as a screening or effectiveness marker in clinical trials such as those for asthma or other immune-mediated inflammatory diseases. Assays for ECP can be done on a variety of sample types. Since ECP assays are not common enough to be run in-house at Covance Central Laboratory Services (CLS), these assays are sent to an external...
Precise Recreation of Processes Yields Confidence: Solving unique challenges with custom heat kill efficacy studies
For food companies, ensuring product safety is essential to protecting their brand-that's why one food manufacturer turned to Covance for a custom heat kill efficacy study involving E. coli 0157:H7.
Identify. Recruit. Results. An Oncology Case Study
See how identifying new sites through a feasibility analysis improved recruitment rates and patient randomization for a HER2-positive metastatic breast cancer study.
Precision Delivery Transforms Results: Oncology Expanded Access Case Study
Learn how an expanded access program was run to collect safety data for a colorectal cancer drug.
Early Development Capabilities in Immuno-Oncology
Learn more about the fast-track to success for a pharmaceutical company developing an innovative new programmed death receptor-1-blocking antibody with centralized analytical and manufacturing support.